This resource describes how state health departments and other public health organizations can partner with people with HIV and/or who use(d) drugs in programmatic and policy making processes and evaluation.
Resources and Tools
Language is foundational to how we understand and interact with ourselves and others. Unclear language can lead to confusion and inefficiencies, while stigmatizing and prejudicial language leads to harmful practices and dehumanizes people.
This guide offers considerations for how state agency staff can develop and maintain an accessible, HIV and opioid use disorder (OUD) service inventory. This guide can be used by state agency HIV and OUD staff to:
Individuals who have HIV who also use drugs experience increased age-matched morbidity and mortality in comparison with those with HIV who do not use drugs.
This document describes the critical role that peers have in developing and delivering care for people with HIV and OUD and how a state’s Medicaid program can serve as an essential fiscal resource in supporting peer services.
This discussion guide is intended to elicit a comprehensive and concrete conversation about language, stigma, and discrimination as a means of strengthening care systems and ensuring that people who seek care for HIV and/or substance use disorders, including opioid use disorder, are treated with
This webinar companion guide offers attendees a resource to supplement the information covered during a webinar and extend the webinar’s benefits beyond the allotted presentation time. It contains:
This tool focuses on the role of stigma at the intersection of HIV and OUD systems, and introduces opportunities for intervention at the systems level.
In Los Angeles, New York, Houston, Philadelphia, and Washington, D.C., a National Institutes of Health funded clinical trial, known as INTEGRA, is evaluating the efficacy of delivering integrated HIV and substance use disorder care via mobile clinics.
A recent study published in Drug and Alcohol Dependence found evidence for racial/ethnic disparities in buprenorphine distribution across the United States.